Minjuvi 200 mg, poudre pour solution à diluer pour perfusion

7680680830017 CH-68083 Puder
Minjuvi 200 mg, poudre pour solution à diluer pour perfusion
Minjuvi 200 mg, poudre pour solution à diluer pour perfusion
Minjuvi 200 mg, poudre pour solution à diluer pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
28/05/2025
Summary of Product Characteristics
Français
28/05/2025
Summary of Product Characteristics
Italien
28/05/2025

Detailed composition

Substance Quantity Type Category
PRC
200.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
7.4 MG Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 754.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2022

Authorization holder

Incyte Biosciences International

1110 Morges

Authorization information

Swissmedic authorization number
68083
Drug name
Minjuvi, poudre pour solution à diluer pour perfusion
Galenic form
PULPI
ATC Code
L01FX12
Authorization status
Z
Dispensing category
A
First authorization
22/03/2022
Authorization expiration date
20/05/2030
IT Number
07.16.1.
Domain
Human medicine
Field of application
diffuses grosszelliges B-Zell Lymphom (DLBCL)

Package details

Description (FR)
MINJUVI subst sèche 200 mg flac
Description (DE)
MINJUVI Trockensub 200 mg Durchstf
Market launch
22/03/2022
Narcotic (BTM)
No